Arabic Arabic English English French French German German
dark

Inconsistent Results Cause Halt to CLN6 Batten Disease Program

​Amicus announced that it is halting its CLN6 Batten disease gene therapy program after studies failed to achieve consistent results. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Nearly 48,000 boosters given yesterday; 14 community cases; 34 people in hospital; two in ICU

Next Post

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

Related Posts
Total
0
Share